[ad_1]

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) — The “Imaging Breast & Prostate Cancer – Technologies, Market Trends and Applications, 2021” report has been added to ResearchAndMarkets.com’s providing.

Breast & Prostate cancers have at all times been within the information as a consequence of their widespread prevalence, nature, complexity and aggressiveness. They are the 2 mostly discovered invasive cancers in men and women, respectively.

In the final couple of many years, the detection, localization and prognosis of those cancers has seen great advances because of know-how and innovation within the discipline of Medical imaging, not too long ago specializing in noninvasive optical methods. Imaging is a crucial a part of most cancers medical protocols and may present quite a lot of details about morphology, construction, metabolism and bodily capabilities.

Biomedical imaging can thus be used within the prediction, staging, screening, prognosis, biopsy steerage for prognosis, plan of therapy, remedy steerage, remedy response recurrence and palliation of those cancers. With rising most cancers danger globally, there’s a increased want for screening and prognosis as early as doable.

Key Features of the Report

Existing, New and Evolving Imaging approaches for detecting and treating Breast & Prostate Cancers

Market income breakdown for the principle Imaging modalities

Market forecast of Imaging modalities from 2020-2026

Presentation of dominant market developments

Summary of ongoing medical trials, funded initiatives, investments and M&A’s for most cancers imaging.

Review of most promising upcoming techniques/units

Study Goals and Objectives

To present an intensive evaluation of the in vivo imaging modalities for breast and prostate most cancers.

To summarize the worldwide overview, prevalence, illness development, developments, laws and present services for imaging breast and prostate most cancers.

To element and describe all of the imaging applied sciences and its market segmentation.

To present the product vary, worth chain, present and upcoming market developments and forecast for imaging these cancers.

To analyse the applied sciences and techniques of the assorted actors and influencers within the worth chain.

Story continues

Key Topics Covered:

1. INTRODUCTION

Study Goals and Objectives

Information sources and methodology

Scope of the report

Glossary

Definitions

List of corporations talked about within the report

2. BREAST & PROSTATE CANCER FACTS

Prevalence

Scanning & Surgeries

3. TECHNOLOGY SEGMENTATION

4. MARKET DATA AND TRENDS

5. NOTICEABLE UPCOMING R & D TECHNOLOGIES

6. REGULATORY ASPECTS

7. CONCLUSIONS

Companies Mentioned

AB-CT

Adani

AGFA Healthcare

Bio Medical International

Canon

CMR Naviscan,

DMS Imaging

Ecoray

Esaote

EXO

GE Healthcare

Genoray

Hologic

IMS Giotto,

Italray

Konica Minolta

Koning

Landwind Medical

Leica Biosystems

Lorad,

Metaltronica S.P.A.

Mindray

MS Westfalia

Panacea Engineering Medicine,

OncoVision

Philips

Planmed

Seno Medical

Siemens Healthineers

SIUI

Shimadzu,

Sternmed

Toshiba

Villa Sistemi Medicali S.P.A.

For extra details about this report go to https://www.researchandmarkets.com/r/1l1nvo

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

[ad_2]

Source link

#Market #Revenue #Breakdown #Main #Imaging #Modalities

By Seth A. Dunbar

Seth A. Dunbar leads clinical research study operations and quality & compliance. His is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published. Required fields are marked *